Historical record - last NADAC effective date: 1/2/2015
Product Information
LOTEMAX 0.5% EYE DROPS is a brand product labeled by Bausch & Lomb Incorporated, priced at $36.7339 per ML under NDC 24208029915. Its NADAC has been published 112 times since Nov 28, 2013.
FDA first approved this application on Mar 9, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the loteprednol etabonate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208029915
Classification
Brand
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
1/2/2015
Active Ingredients
LOTEPREDNOL ETABONATEApproval Type
New Drug (NDA)
FDA Application
NDA020583FDA Approved
3/9/1998
TE Code
AB
On Market Since
3/9/1998
Pharmacological Classes
Price Statistics
The NADAC for LOTEMAX 0.5% EYE DROPS has been published 112 times since Nov 28, 2013, and over the history we have for it it has risen 46.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $36.7339 per ML |
|---|---|
| All-time high | $36.7339 (Jan 13, 2016) |
| All-time low | $25.1045 (Nov 28, 2013) |
| Median price | $33.3944 |
| Average price | $33.5505 |
| Largest weekly change | +20.0% (May 7, 2014) |
| Weeks tracked | 112 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+46.3%
Last surveyed Jan 13, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 71% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOTEMAX 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for LOTEMAX 0.5% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $36.7339 per ML (NDC 24208029915), effective Jan 13, 2016.
How has the price of LOTEMAX 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for LOTEMAX 0.5% EYE DROPS has risen 46.3%. It has been tracked across 112 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOTEMAX 0.5% EYE DROPS?
Since Nov 28, 2013, the NADAC for LOTEMAX 0.5% EYE DROPS has ranged from a low of $25.1045 (Nov 28, 2013) to a high of $36.7339 (Jan 13, 2016), with a median of $33.3944 per ML.
Are there cheaper alternatives to LOTEMAX 0.5% EYE DROPS?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOTEPREDNOL ETABONATE 0.5% DRP, is $10.5316 per ML — about 71% below LOTEMAX 0.5% EYE DROPS.
Who manufactures LOTEMAX 0.5% EYE DROPS?
LOTEMAX 0.5% EYE DROPS (NDC 24208029915) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.